Drug re-purposing by targeting Dengue and CHIKV

One of our long standing dream to use drug re-purpose or repositioning strategy on neglected tropical diseases such as Dengue or CHIKV was finally successful with the publication of the latest article entitled “Reaching beyond HIV/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus” in RSC Advances (LINK). We are in process to further boost the selectivity index using computer aided drug design strategy.